What are Presentations of Neuroblastoma?
Discussion
Abdominal pain is a very common problem with abdominal masses being somewhat less common. If one considers how frequently patients have abdominal pain due to constipation and that it often presents with a fecal mass, both of these are commonplace. Abdominal and pelvic organs are sometimes mistaken for masses also. As the abdominal and pelvic cavities are large, tumors often need to be quite large before they cause functional problems and/or can be palpated on physical examination.
A review of abdominal masses can be found here.
A review of recurrent abdominal pain can be found here.
A review of acute abdominal p...
Source: PediatricEducation.org - March 27, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
A Pentagon Study Finds Higher Cancer Rates in Military Pilots and Ground Crews
WASHINGTON — A Pentagon study has found high rates of cancer among military pilots and for the first time has shown that ground crews who fuel, maintain and launch those aircraft are also getting sick.
The data had long been sought by retired military aviators who have raised alarms for years about the number of air and ground crew members they knew who had cancer. They were told that earlier military studies had found they were not at greater risk than the general U.S. population.
In its yearlong study of almost 900,000 service members who flew on or worked on military aircraft between 1992 and 2017, the Pentagon fo...
Source: TIME: Health - March 20, 2023 Category: Consumer Health News Authors: Tara Copp/AP Tags: Uncategorized Cancer healthscienceclimate wire Source Type: news
Trial Casts Shadow on Photodynamic Surgery for Bladder Cancer Trial Casts Shadow on Photodynamic Surgery for Bladder Cancer
Photodynamic diagnosis-guided TURBT did not reduce 3-year recurrence rates of non –muscle-invasive bladder cancer in a real-world trial compared with white light-guided cystoscopy.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 15, 2023 Category: Pathology Tags: Hematology-Oncology News Source Type: news
Urine Test Predicts Future Bladder Cancer 12 Years Before Symptoms Urine Test Predicts Future Bladder Cancer 12 Years Before Symptoms
A 10-gene assay predicted future cases of urothelial cancer, the most common form of bladder cancer, with a high degree of sensitivity and specificity.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 13, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Gemcitabine, Docetaxel a Viable Alternative to BCG in Bladder Cancer
MONDAY, March 13, 2023 -- For patients with non-muscle invasive bladder cancer (NMIBC), gemcitabine and docetaxel therapy is associated with less high-grade disease recurrence, according to a study published online Feb. 28 in JAMA Network Open.
Ian... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 13, 2023 Category: Pharmaceuticals Source Type: news
Study: Testing urine for genetic mutations may detect bladder cancer early
Identifying genetic mutations in urine could help detect bladder cancer years before symptoms arise, a new study presented Friday at the European Association of Urology annual congress in Milan found. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 10, 2023 Category: Consumer Health News Source Type: news
Gemcitabine-Docetaxel Effective Alternative to BCG in NMIBC Gemcitabine-Docetaxel Effective Alternative to BCG in NMIBC
The chemotherapy duo performed better than expected as a stand-in for bacillus Calmette-Gu érin (BCG), which is the gold standard for non–muscle-invasive bladder cancer but is currently in short supply.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 7, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Man spotted an alarming symptom of bladder cancer while finishing up on the loo - symptoms
David Day, from Cambridge, first noticed a worrisome sign of cancer in December 2013. (Source: Daily Express - Health)
Source: Daily Express - Health - March 4, 2023 Category: Consumer Health News Source Type: news
Possible Role for Ipilimumab in Metastatic Bladder Cancer, Study Suggests
(MedPage Today) -- A tailored immunotherapy regimen using nivolumab (Opdivo) induction and "boosts" with nivolumab and high-dose ipilimumab (Yervoy) as second-line treatment for metastatic urothelial cancer was associated with higher response rates... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 2, 2023 Category: Hematology Source Type: news
Pembrolizumab Activity in BCG-Refractory Papillary Bladder Cancer Pembrolizumab Activity in BCG-Refractory Papillary Bladder Cancer
Pembrolizumab monotherapy showed promising antitumor activity for patients with high-risk non –muscle invasive bladder cancer that did not respond to standard treatment with BCG.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - February 27, 2023 Category: Transplant Surgery Tags: Hematology-Oncology News Source Type: news
Adjuvant Nivolumab as Standard of Care in Resected Bladder Cancer Adjuvant Nivolumab as Standard of Care in Resected Bladder Cancer
Extended follow-up from the CheckMate 274 trial further supports adjuvant nivolumab as a standard of care for patients with resected muscle-invasive urothelial carcinoma.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 20, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years
GSK Scientists Knew About Zantac's Cancer Risks For Forty Years Three years after the Food & Drug Administration (FDA) pulled GSK Plc's heartburn drug Zantac off the market due to suspected links to cancer, and just two weeks before the trial begins of a man who alleges he developed bladder cancer…#fda #gskplc #gsk #zantac #glaxo #ndma #931ng #eveliogrillo (Source: Reuters: Health)
Source: Reuters: Health - February 20, 2023 Category: Consumer Health News Source Type: news
Pembrolizumab Active in BCG-Unresponsive Papillary High-Risk Bladder Cancer
(MedPage Today) -- SAN FRANCISCO -- Pembrolizumab (Keytruda) monotherapy showed encouraging antitumor activity in patients with papillary high-risk non-muscle-invasive bladder cancer (HR NMIBC) that was unresponsive to Bacillus Calmette-Guerin... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 19, 2023 Category: Hematology Source Type: news
Judge Weighs Key Evidence Ahead of First Zantac Cancer Trial Judge Weighs Key Evidence Ahead of First Zantac Cancer Trial
Lawyers for a man who alleges he developed bladder cancer after taking heartburn drug Zantac urged a California judge on Thursday to allow expert testimony at an upcoming trial.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 17, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Thousands of people can't get full treatments of a lifesaving cancer drug
Dino Carlone was frightened when he was diagnosed with bladder cancer three years ago, but his spirits were buoyed when he learned that he could get help from a highly effective drug with a great track record. (Source: CNN.com - Health)
Source: CNN.com - Health - February 15, 2023 Category: Consumer Health News Source Type: news
